Eiko Lifescience, a company in the Specialty Chemicals industry, reported revenue of ₹18 crore and net profit of ₹1.56 crore for the September 2026 quarter.
Eiko Lifescience (BSE: EIKO) closed at ₹51.78 on 20 Nov 2026, down 2.5% over the past year. Its market capitalisation is ₹76 crore and it trades at 14.7 times earnings.
Incorporated in 2021, Eiko LifeSciences Ltd manufacturing & sells Specialty Chemical and Fine Chemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.